An independent comparison, read through an endo lens
You counted the appointments. You kept the pain diary no one read. You were handed a diet sheet and sent home to try harder. Havelle begins somewhere else — by believing you — and then looks, carefully, at which providers offer metabolic care as though the rest of you exists.
A note we make first, and keep everywhere: metabolic and weight care is one pillar of whole-woman care that sits alongside endometriosis-specific treatment. GLP-1 medications, including compounded tirzepatide, are not a treatment for endometriosis.
Havelle is an independent editorial comparison of telehealth providers who prescribe compounded GLP-1 medication. We read sixteen of them against one question women with endometriosis rarely get to ask out loud: will this provider treat me as a whole person, or as a number on a chart? No provider pays to appear here or to rank, we list them alphabetically, and the rating never moves for money.
The Whole-Woman Charter
Before you compare anyone, it helps to know what “good” should feel like. These are the seven promises we hold every provider against, each with why it matters when you live with endo.
Reads your full history — pain and hormones included — and never reduces you to a number on a chart.
Care built to listen, without the “just lose weight” brush-off you have already heard.
Takes weight, insulin and inflammation seriously as one part of your plan, and never pretends it treats endometriosis.
503A compounded titration matched to how you respond, not a one-size ladder.
Real help, quickly, when something goes wrong.
Maintenance and a medically guided step-down, so results hold.
Pricing you can read before you commit.
The Whole-Care Match
We weight the seven promises by what has worn you down and what would help most, then filter by budget. Nothing here is pay-to-play — the same honest scores drive every result.
The comparison
The petals show how each provider scored across the seven promises; the bloom sums them into a Whole-Care Rating. Price sits in its own column — it never moves a provider up or down.
Reading room
The average endometriosis diagnosis takes seven to ten years. Here is what happens across those years — and why the delay was never a measure of your effort.
Read the guide → The honest lineWeight, insulin and inflammation deserve honest attention. But GLP-1 medications, including compounded tirzepatide, do not treat endometriosis, its lesions or its pain — this is about caring for the whole body around the disease, never the disease itself.
Read the guide → The first visitFive questions to ask — and three answers to listen for — that reveal whether you are being seen or simply sorted.
Read the guide →Trust & method
A rating you can read at a glance, a formula that does not move for money, and one line we hold everywhere: GLP-1 medications are not a treatment for endometriosis.